Aviv Regev

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Aviv Regev
Aviv Regev ISMB 2017 (cropped).jpg
Aviv Regev at the Intelligent Systems for Molecular Biology conference in 2017
Alma materTel Aviv University
Awards
Scientific career
FieldsBioinformatics
Computational Biology
Institutions
Doctoral advisorEva Jablonka
Ehud Shapiro
Websitebroadinstitute.org/bios/aviv-regev

Aviv Regev is a computational biologist at the Broad Institute of MIT and Harvard and a Professor in the department of biology at Massachusetts Institute of Technology[3] and an Investigator at the Howard Hughes Medical Institute.[4]

Education[edit]

Regev completed her Ph.D. at Tel Aviv University under the supervision of Eva Jablonka[5] and Ehud Shapiro.[6]

Research[edit]

Regev's highly cited[7][8] research includes work on gene expression[9][10] (with Eran Segal and David Botstein), and the use of π-calculus to represent biochemical processes.[11][12]

Awards and honors[edit]

Regev was awarded the Overton Prize in 2008 for "outstanding accomplishment to a scientist in the early to mid stage of his or her career".[1] She was awarded the ISCB Innovator Award in 2017.[2][13] She was also awarded the NIH Director's Pioneer Award[when?][citation needed] and the Burroughs Wellcome Fund Career Award.[citation needed][when?] In 2017, she was awarded a Paul Marks Prize for Cancer Research.[14]

She was elected to the National Academy of Sciences in 2019.[15]

References[edit]

  1. ^ a b Sansom, C.; Morrison Mckay, B. J. (2008). Bourne, Philip E. (ed.). "ISCB Honors David Haussler and Aviv Regev". PLOS Computational Biology. 4 (7): e1000101. doi:10.1371/journal.pcbi.1000101. PMC 2536508. PMID 18795145. open access
  2. ^ a b Fogg, Christiana N.; Kovats, Diane E.; Berger, Bonnie (2017). "2017 ISCB Innovator Award: Aviv Regev". PLOS Computational Biology. 13 (6): e1005558. doi:10.1371/journal.pcbi.1005558. ISSN 1553-7358. PMC 5493285. PMID 28665936. open access
  3. ^ "Aviv Regev at MIT". biology.mit.edu.
  4. ^ "Aviv Regev, PhD: Investigator / 2014–Present". hhmi.org. Howard Hughes Medical Institute.
  5. ^ Regev, A.; Lamb, M. J.; Jablonka, E. (1998). "The Role of DNA Methylation in Invertebrates: Developmental Regulation or Genome Defense?". Molecular Biology and Evolution. 15 (7): 880. doi:10.1093/oxfordjournals.molbev.a025992. ISSN 0737-4038.
  6. ^ Regev, A.; Shapiro, E. (2002). "Cellular abstractions: Cells as computation". Nature. 419 (6905): 343. doi:10.1038/419343a. PMC 3842595. PMID 12353013. closed access
  7. ^ "Aviv Regev publications in Google Scholar". scholar.google.com.
  8. ^ Search Results for author Regev A on PubMed.
  9. ^ Segal, E.; Shapira, M.; Regev, A.; Pe'er, D.; Botstein, D.; Koller, D.; Friedman, N. (2003). "Module networks: Identifying regulatory modules and their condition-specific regulators from gene expression data". Nature Genetics. 34 (2): 166–176. doi:10.1038/ng1165. PMID 12740579.
  10. ^ Segal, E.; Friedman, N.; Koller, D.; Regev, A. (2004). "A module map showing conditional activity of expression modules in cancer". Nature Genetics. 36 (10): 1090–1098. doi:10.1038/ng1434. PMC 2271138. PMID 15448693. closed access
  11. ^ Regev, A.; Silverman, W.; Shapiro, E. (2001). "Representation and simulation of biochemical processes using the pi-calculus process algebra". Pacific Symposium on Biocomputing: 459–470. PMID 11262964.
  12. ^ Priami, C.; et al. (2001). "Application of a stochastic name-passing calculus to representation and simulation of molecular processes". Information Processing Letters. 80: 25–31. doi:10.1016/S0020-0190(01)00214-9. closed access
  13. ^ "February 09, 2017: ISCB Announces 2017 Award Recipients". www.iscb.org. Retrieved 10 February 2017.
  14. ^ "2017 Prize Winners". Memorial Sloan Kettering Cancer Center. Retrieved 12 December 2017.
  15. ^ "2019 NAS Election". www.nasonline.org. Retrieved 30 April 2019.